US link-up to develop tissue regeneration products:
This article was originally published in Clinica
Executive Summary
Osiris Therapeutics and California-based Activated Cell Therapy have agreed to develop structural and connective tissue regeneration products. Osiris will have exclusive rights to use Activated Cell Therapy's cell isolation and enrichment technology for the recovery of mesenchymal stem cells. Osiris, based in Baltimore, Maryland, intends to use the stem cells to develop cell therapy products to treat diseased or damaged structural and connective tissues.
You may also be interested in...
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.